Success Story: EB-1A Approved After RFE Challenging the Major Significance of AI Research Contributions
Client’s Testimonial:
“Thank you so much for all your help throughout the process, especially with preparing the RFE response and supporting materials. I really appreciate all the time and effort you and the team put into my case. Thank you again for helping make this happen!”
On September 26th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for an Applied Scientist in the Field of Artificial Intelligence (Approval Notice).
General Field: Artificial Intelligence
Position at the Time of Case Filing: Applied Scientist
Country of Origin: China
Country of Residence at the Time of Filing: China
Approval Notice Date: September 26th, 2026
Processing Time: 16 months, 13 days (Premium Processing Requested)
Case Summary:
For this EB-1A petition, the central challenge was not establishing that the client had published influential artificial intelligence research, but demonstrating that those contributions had achieved major significance within the field. The client specialized in machine learning, deep learning, and privacy in healthcare, with research focused on privacy-preserving medical data sharing. The Request for Evidence (RFE), issued on June 24th, 2026, questioned whether the original contributions met the required level of significance. North America Immigration Law Group (Chen Immigration Law Associates) therefore developed a response centered on documented implementation, independent recognition, and the client's standing within this specialized area of artificial intelligence.
The response highlighted particularly compelling evidence of practical implementation, including a granted U.S. commercial patent that incorporated the client's research into its privacy assessment, a U.S. policy research institution that applied the client's privacy attack testing methodology, and government researchers who relied on the client's findings to evaluate privacy risks associated with medical information sharing. These examples provided concrete evidence that the client's contributions had influenced research practices beyond the original publications.
The client's academic achievements and professional recognition further supported the EB-1A petition. At the time of filing, the client had accumulated 423 citations, which had increased to 770 citations by the time of the RFE response. Additional qualifications included:
- 8 peer-reviewed journal articles, 4 peer-reviewed conference articles,
- At least 12 peer reviews completed for respected journals and conferences.
- Research supported by the National Institutes of Health (NIH) and the National Science Foundation (NSF).
These achievements were presented alongside evidence of the client's contributions to research involving synthetic medical records, data privacy, and advanced machine learning methods.
The RFE response ultimately addressed both the disputed original-contributions criterion and the broader final merits determination required for EB-1A classification. By connecting independent institutional adoption, recognized research contributions, scholarly achievements, and sustained international attention, North America Immigration Law Group presented a comprehensive argument that the client had achieved the level of distinction required for extraordinary ability classification.
Following the petition's filing on May 13th, 2025, a premium processing upgrade on June 10th, 2026, and the subsequent RFE response, USCIS approved the EB-1A petition on September 26th, 2026. The approval supports the client's plans to continue advancing artificial intelligence research, particularly in developing efficient synthetic data generation methods and improving the accessibility and responsible use of data.